Plexision

About Plexision

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, infectious diseases, and immunological disorders. Their mission is to advance personalized medicine for better health through innovative diagnostic testing and R&D projects that integrate biomarker targets in all phases of drug development.

Products & Services

PleximmuneTM:An FDA-approved blood test to predict the risk of acute cellular rejection after liver or intestine transplantation in children.

PlexABMRTM:A blood test to assess the risk of antibody-mediated rejection of a transplanted organ.

PlexCMVTM:A blood test to measure the level of cellular immunity to Cytomegalovirus (CMV).

COVID-19 Antibody Testing:A lab-developed blood test that detects the presence of antibodies to the SARS-CoV-2 virus.

Lymphocyte Subsets:A blood test to measure counts and relative frequencies of T-, B-, and Natural-killer lymphocytes.

Antigen Stimulation:A blood test to measure T-cell immunity to common viruses like Cytomegalovirus and Epstein-Barr virus.

Mitogen Stimulation:A blood test to measure a patient's general cellular immune response to common mitogens.

Immuno-Oncology (Drug Selection):A blood test to characterize tumor antigenicity, anti-tumor responses, and modulation with specific immune checkpoint inhibitors.

Biomarkers (Services):Custom R&D projects aimed at integrating biomarker targets in all phases of drug development.

Specialties

Cellular Biomarkers Personalized Diagnostics Solid Organ Transplantation Immunological Disorders Infectious Diseases Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 365000 MR: - FA: $365,000 FAN: 365000	D: 2025-07-24 FD: 2025-07-24	1 investors

Grant Latest

2025-07-24

$365K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rakesh Sindhi

Transplant Surgeon, Co-founder, Chief Scientific Officer and Chief Executive Officer at Plexision, Raizman-Haney Chair, Professor of Surgery, Co-Director of Pediatric Transplant Surgery, and Director of the Center for Computational Immunogenetics and Drug Repurposing at the University of Pittsburgh

A

Ashok Reddy

Director of Operations

B

Brandon W. Higgs

Advisor to Plexision in the areas of Computational Immunogenetics and AI

K

Kate Lederman

Senior Sales Executive & Field Sales Trainer at Becton Dickinson (BD) Medical

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Plexision Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised